(Q39970717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Regulatory T cells delay disease progression in Alzheimer-like pathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Nicolas Cagnard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Martin Holzenberger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Eliane Piaggio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Guillaume Dorothee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Cira Dansokho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Dylla Ait Ahmed

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Cécile Toly-Ndour

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Thomas Chaigneau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Vanessa Calle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pierre Aucouturier

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

1 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

Pt 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1237-1251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

The interleukin-1 receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Alzheimer disease models and human neuropathology: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

USP18 lack in microglia causes destructive interferonopathy of the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Wnt signaling in the nervous system and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Microglial priming in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Sublime microglia: expanding roles for the guardians of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

PD1 Negative and PD1 Positive CD4+ T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWV408

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWV408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26912648%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference